Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)

NCT03471728 · clinicaltrials.gov ↗

COMPLETED

Status

2475

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases)
Irritable Bowel Syndrome With Constipation (IBS-C)

Interventions

DRUG: linaclotide

Sponsor

Astellas Pharma Inc